COMPANY NAME |
REVENUES 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Q1 2025 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE A Quarter Before Q4 2024 |
Contineum Therapeutics Inc |
0.00 |
0.00% |
0.00 % |
0.00 % |
Johnson and Johnson |
89,331.00 |
11.92% |
12.03% |
11.62% |
Merck and Co Inc |
63,922.00 |
8.53% |
8.53% |
8.07% |
Pfizer Inc |
62,463.00 |
8.33% |
7.53% |
9.17% |
Abbvie Inc |
57,367.00 |
7.65% |
7.33% |
7.80% |
Sanofi |
49,599.72 |
6.62% |
6.62% |
0.00% |
Eli Lilly And Company |
49,003.20 |
6.54% |
6.99% |
6.99% |
Bristol myers Squibb Company |
47,636.00 |
6.36% |
6.15% |
6.37% |
Novartis Ag |
46,660.00 |
6.22% |
6.22% |
0.00% |
Astrazeneca Plc |
45,811.00 |
6.11% |
6.11% |
0.00% |
Abbott Laboratories |
42,344.00 |
5.65% |
5.69% |
5.66% |
Amgen Inc |
33,424.00 |
4.46% |
4.99% |
4.39% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
3.89% |
3.89% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
3.83% |
3.66% |
3.91% |
Teva Pharmaceutical Industries Limited |
16,617.00 |
2.22% |
2.14% |
2.18% |
Viatris Inc |
14,330.20 |
1.91% |
1.79% |
1.82% |
Regeneron Pharmaceuticals Inc |
14,085.70 |
1.88% |
1.66% |
1.96% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.48% |
1.52% |
1.50% |
Biogen Inc |
9,816.40 |
1.31% |
1.34% |
1.27% |
Bausch Health Companies Inc |
9,731.00 |
1.30% |
1.24% |
1.32% |
Organon and Co |
6,294.00 |
0.84% |
0.83% |
0.82% |
Jazz Pharmaceuticals Plc |
4,064.81 |
0.54% |
0.49% |
0.56% |
Horizon Therapeutics Public Limited Company |
3,643.45 |
0.49% |
0.52% |
0.43% |
Adhera Therapeutics Inc |
2,732.01 |
0.36% |
0.00% |
0.00% |
Royalty Pharma Plc |
2,263.85 |
0.30% |
0.31% |
0.31% |
Sarepta Therapeutics Inc |
2,233.37 |
0.30% |
0.41% |
0.34% |
Ptc Therapeutics inc |
900.03 |
0.12% |
0.00% |
0.10% |
Biohaven Ltd |
859.68 |
0.11% |
0.00% |
0.00% |
Opko Health Inc |
689.41 |
0.09% |
0.08% |
0.09% |
Kiniksa Pharmaceuticals International Plc |
481.17 |
0.06% |
0.08% |
0.06% |
Arvinas Inc |
426.90 |
0.06% |
0.10% |
0.03% |
Innoviva Inc |
408.35 |
0.05% |
0.04% |
0.05% |
Myovant Sciences Ltd |
379.11 |
0.05% |
0.06% |
0.05% |
Mannkind Corporation |
297.60 |
0.04% |
0.04% |
0.04% |
Legend Biotech Corporation |
285.14 |
0.04% |
0.04% |
0.00% |
Galapagos Nv |
268.49 |
0.04% |
0.04% |
0.00% |
Morphosys Ag |
266.87 |
0.04% |
0.04% |
0.00% |
Esperion Therapeutics Inc |
259.57 |
0.03% |
0.04% |
0.04% |
Puma Biotechnology Inc |
232.71 |
0.03% |
0.03% |
0.03% |
Amylyx Pharmaceuticals Inc |
196.49 |
0.03% |
0.00% |
0.00% |
Prothena Corporation Public Limited Company |
137.94 |
0.02% |
0.00% |
0.00% |
Xencor Inc |
127.23 |
0.02% |
0.02% |
0.03% |
Anaptysbio inc |
111.87 |
0.01% |
0.02% |
0.02% |
Spectrum Pharmaceuticals Inc |
109.33 |
0.01% |
0.01% |
0.01% |
Zymeworks Inc |
93.38 |
0.01% |
0.01% |
0.02% |
Nektar Therapeutics |
87.25 |
0.01% |
0.01% |
0.02% |
Fortress Biotech Inc |
57.78 |
0.01% |
0.01% |
0.01% |
Journey Medical Corp |
56.24 |
0.01% |
0.01% |
0.01% |
Aquestive Therapeutics Inc |
54.23 |
0.01% |
0.00% |
0.01% |
Integrated Biopharma Inc |
53.38 |
0.01% |
0.01% |
0.01% |
Sage Therapeutics Inc |
47.40 |
0.01% |
0.01% |
0.01% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Mereo Biopharma Group Plc |
36.46 |
0.00% |
0.00% |
0.00% |
Lexicon Pharmaceuticals Inc |
31.21 |
0.00% |
0.00% |
0.01% |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00% |
0.00% |
Bicycle Therapeutics Plc |
25.72 |
0.00% |
0.01% |
0.00% |
Allarity Therapeutics Inc |
23.79 |
0.00% |
0.00% |
0.00% |
Abcellera Biologics Inc |
23.11 |
0.00% |
0.00% |
0.00% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Nuvation Bio Inc |
10.79 |
0.00% |
0.00% |
0.00% |
Xilio Therapeutics inc |
9.27 |
0.00% |
0.00% |
0.00% |
Xbiotech Inc |
8.21 |
0.00% |
0.00% |
0.00% |
Dianthus Therapeutics Inc |
6.52 |
0.00% |
0.00% |
0.00% |
Prometheus Biosciences Inc |
4.00 |
0.00% |
0.00% |
0.00% |
Dmk Pharmaceuticals Corporation |
3.53 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Palatin Technologies Inc |
2.18 |
0.00% |
0.00% |
0.00% |
Summit Therapeutics Inc |
2.08 |
0.00% |
0.00% |
0.00% |
Galmed Pharmaceuticals Ltd |
2.04 |
0.00% |
0.00% |
0.00% |
Aptinyx Inc |
1.75 |
0.00% |
0.00% |
0.00% |
Addex Therapeutics Ltd |
1.61 |
0.00% |
0.00% |
0.00% |
Immuron Limited |
1.48 |
0.00% |
0.00% |
0.00% |
Hcw Biologics Inc |
1.45 |
0.00% |
0.00% |
0.00% |
Therapeuticsmd Inc |
1.41 |
0.00% |
0.00% |
0.00% |
Timber Pharmaceuticals Inc |
0.88 |
0.00% |
0.00% |
0.00% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Actavia Life Sciences Inc |
0.12 |
0.00% |
0.00% |
0.00% |
Sangui Biotech International Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Innovation1 Biotech Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Xtl Biopharmaceuticals Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Connect Biopharma Holdings Limited |
0.00 |
0.00% |
0.00% |
0.01% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Zyversa Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Gri Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Synaptogenix Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Evelo Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nexien Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Respirerx Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acelyrin Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Aeon Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Azitra Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cohbar Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Dice Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Annexon Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tiziana Life Sciences Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
180 Life Sciences Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Renovorx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Ventyx Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Protokinetix Incorporated |
0.00 |
0.00% |
0.00% |
0.00% |
Eledon Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Bullfrog Ai Holdings Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Calcimedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Edesa Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Third Harmonic Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cassava Sciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Belite Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Arrivent Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Os Therapies Incoporated |
0.00 |
0.00% |
0.00% |
0.00% |
Biostax Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Atea Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Medicinova Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Prelude Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eqrx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Beigene Ltd |
0.00 |
0.00% |
0.61% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biophytis Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Galecto Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Protagenic Therapeutics Inc new |
0.00 |
0.00% |
0.00% |
0.00% |
Satsuma Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nanoviricides inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cerevel Therapeutics Holdings Inc |
0.00 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
749,560.20 |
100% |
182,033.82 |
100% |
CTNM's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
CTNM's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
Note: Market share is calculated based on total revenue. To get a more accurate picture of Contineum Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit
Contineum Therapeutics Inc's Business Segment.
The list includes publicly traded companies only. More information about the sources of this report can be found
here.